【摘要】 目的 探讨有氧康复运动治疗慢性心力衰竭的疗效及安全性。方法 回顾性分析120例慢性心衰患者的临床资料,在基础药物治疗前提下,根据有无实施有氧康复治疗随机分为2组:A组60例为有氧康复治疗组,B组60例为未实行有氧康复治疗组即对照组。A组患者自入院开始即开始康复运动,心功能Ⅱ级以上者严格按照有氧康复运动方案进行锻炼。比较两组入院及1年后NYHA心功能分级、BNP、LVEF、LVED、6 min步行试验距离、再住院率及死亡率。结果 A、B两组组内比较,1年后NYHA心功能分级,BNP、LVEF、LVED均较入院时好转(P<0.05)。A、B两组组间比较,入院时NYHA心功能分级,BNP、LVEF、LVED差异无统计学意义(P>0.05),1年后A组患者明显优于B组患者(P<0.05),且6 min步行距离较B组明显增加(P<0.05),再住院率及死亡率下降(P<0.05)。结论 有氧康复运动作为药物治疗的补充,安全有效,适宜慢性心力衰竭患者二级预防治疗。更多还原

【Abstract】 Objective To investigate the efficacy and safety of aerobic exercise rehabilitation in chronic heart failure.Methods A retrospective analysis of 120 patients with chronic heart failure.All the patients were divided into 2 groups according to whether the implementation of aerobic exercise rehabilitation.Group A was the aerobic rehabilitation group with 60 cases.Group B was the control group with 60 cases.Group A patients from admission to start rehabilitation exercise,to the heart function Ⅱ more strictly in accordance with the exercise rehabilitation exercise program with oxygen.The NYHA,BNP,EF,LVED,6 minutes walk test distance、rehospitalization rate and mortality were observed from hospital admission to 1 year later.Results After one year,the NYHA,BNP,EF,LVED were better than from admission within A and B groups(P<0.05).The NYHA,BNP,EF,LVED had no significant change in A and B groups from admission(P>0.05).But the A group was significantly higher than that of B group(P<0.05) after one year.The6 minutes walking distance was larger than that of the B group(P<0.05) and readmission and mortality decreased(P<0.05) after 1 year.Conclusion Supplemental aerobic exercise rehabilitation as drug therapy is safe and effective,suitable for secondary prevention therapy in patients with chronic heart failure secondary prevetion.更多还原